Bell Rock Capital LLC Bristol Myers Squibb CO Transaction History

Bell Rock Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $12,064 - $17,531	-260 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $42 - $50	1 Added 0.39%	260 $13,000
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $20,882 - $23,091	-468 Reduced 64.37%	259 $0
Q1 2019 Apr 08, 2019	SELL	$45.12 - $53.8 $41,690 - $49,711	-924 Reduced 55.97%	727 $34,000
Q4 2018 Jan 25, 2019	SELL	$48.76 - $63.23 $97,520 - $126,460	-2,000 Reduced 54.78%	1,651 $85,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $55 - $62	1 Added 0.03%	3,651 $227,000
Q4 2017 Nov 13, 2018	BUY	$59.94 - $65.35 $59 - $65	1 Added 0.03%	3,650 $223,000
Q3 2017 Dec 06, 2018	BUY	$55.23 - $63.74 $110,460 - $127,480	2,000 Added 121.29%	3,649 $232,000
Q2 2017 Dec 06, 2018	BUY	N/A	1 Added 0.06%	1,649 $92,000
Q4 2016 Dec 05, 2018	BUY	N/A	1,648	1,648 $96,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bell Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bell Rock Capital LLC with notifications on news.